Clovis Oncology Raises $145M
Boulder, Colorado-based Clovis Oncology reports today that it has raised a huge, $145M funding round, for the firm's efforts to acquire, develop, and commercialize anti-cancer agents. The funding came from Domain Associates, New Enterprise Associates, Versant Ventures, Aberdare Ventures, Abingworth, Frazier Healthcare Ventures, and ProQuest Investments. Clovis was founded by former executives from Pharmion Corporation, including Patrick Mahaffy, Andrew Allen, Gillian Ivers-Read, and Erle Mast. Mahaffy was founder of Pharmion, which was acquired last year for $2.9B by Celgene.
posted on Thursday, May 21, 2009 (Link to more information)
Related companies:
Clovis Oncology
Related stories:
> Clovis Oncology Prices IPO
> Clovis Oncology Raises $130M In IPO
> Clovis Oncology Files For IPO
> Clovis Oncology On Tap For IPO
> Clovis Oncology Raising $170M in Public Offering
Techrockies.com Home